Vaniprevir is a direct-acting antiviral small molecule that competitively inhibits the hepatitis C virus NS3/4A protease, thereby blocking viral replication. It has been utilized in both in vitro enzymatic assays and in vivo animal studies to investigate HCV protease function and antiviral therapy.
Molekulargewicht:
757.94
Reinheit:
97.41% (May vary between batches)
CAS Nummer:
[923590-37-8]
Formel:
C38H55N5O9S
Target-Kategorie:
HCV Protease
Anwendungsbeschreibung:
Solubility: DMSO:8 mg/mL (10.55 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten